Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 1, 2011, Pages

  Diamond Stanic, Maggie K ^a   Romero Aleshire, Melissa J ^a   Hoyer, Patricia B ^a   Greer, Kevin ^b   Hoying, James B ^b,c   Brooks, Heddwen L ^a  

^a Department of Surgery   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

4 vinylcyclohexene diepoxide; Estrogen; Microarray

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; CYCLOHEXANE OXIDE; HISTIDINE DECARBOXYLASE; MIDKINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLIMACTERIUM; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; IMMEDIATE EARLY GENE; KIDNEY CORTEX; MENOPAUSE; MIG6 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; UPREGULATION; USP2 GENE; VANIN 1 GENE; WESTERN BLOTTING;

EID: 78651343806     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00249.2010     Document Type: Article

References (44)

1. Breyer JA, Bain RP, Evans JK, Nahman NS Jr, Lewis EJ, Cooper M, McGill J, Berl T. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int 50: 1651-1658, 1996.
2. Brooks HL, Ageloff S, Kwon TH, Brandt W, Terris JM, Seth A, Michea L, Nielsen S, Fenton R, Knepper MA. cDNA array identification of genes regulated in rat renal medulla in response to vasopressin infusion. Am J Physiol Renal Physiol 284: F218-F228, 2003.
3. + transporter abundances in NHE3 and NCC null mice using targeted proteomics. J Physiol 530: 359-366, 2001.
4. Chin M, Isono M, Isshiki K, Araki Si Sugimoto T, Guo B, Sato H, Haneda M, Kashiwagi A, Koya D. Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. Am J Pathol 166: 1629-1636, 2005.
5. Coggins C, Lewis J, Caggiula A, Castaldo L, Klahr S, Wang S, Beck G. Differences between women and men with chronic renal disease. Nephrol Dial Transplant 13: 1430-1437, 1998.
6. Dixon A, Maric C. 17β-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signaling. Am J Physiol Renal Physiol 293: F1678-F1690, 2007.
7. Ferby I, Reschke M, Kudlacek O, Knyazev P, Pante G, Amann K, Sommergruber W, Kraut N, Ullrich A, Fassler R, Klein R. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med 12: 568-573, 2006.
8. Graff-Iversen S, Thelle DS, Hammar N. Serum lipids, blood pressure and body weight around the age of the menopause. Eur J Cardiovasc Prev Rehabil 15: 83-88, 2008. (Pubitemid 351263260)
9. Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ, Lechpammer M, Huesken D, Zimmermann J, Signoretti S, Loda M. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5: 253-261, 2004.
10. Greer KA, McReynolds MR, Brooks HL, Hoying JB. CARMA: a platform for analyzing microarray datasets that incorporate replicate measures. BMC Bioinformatics 7: 149, 2006.
11. Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W, Maruyama S, Ito Y, Kobori H, Ikematsu S, Nishiyama A, Matsuo S, Kadomatsu K. The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest 119: 1616-1625, 2009.
12. Iwashita N, Muramatsu H, Toriyama K, Torii S, Muramatsu T. Expression of midkine in normal and burn sites of rat skin. Burns 25: 119-124, 1999.
13. Jabara S, Christenson LK, Wang CY, McAllister JM, Javitt NB, Dunaif A, Strauss JF 3rd. Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab 88: 484-492, 2003.
14. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH. Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl 71: S101-S105, 1999. (Pubitemid 29304825)
15. Keck M, Romero-Aleshire MJ, Cai Q, Hoyer PB, Brooks HL. Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause. Am J Physiol Renal Physiol 293: F193-F199, 2007.
16. Kerr MK, Martin M, Churchill GA. Analysis of variance for gene expression microarray data. J Comput Biol 7: 819-837, 2000.
17. Kosugi T, Yuzawa Y, Sato W, Arata-Kawai H, Suzuki N, Kato N, Matsuo S, Kadomatsu K. Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Lab Invest 87: 903-913, 2007.
18. Kosugi T, Yuzawa Y, Sato W, Kawai H, Matsuo S, Takei Y, Muramatsu T, Kadomatsu K. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol 168: 9-19, 2006.
19. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85: 645-651, 2000. (Pubitemid 32273648)
20. T method. Methods 25: 402-408, 2001.
21. Lohff JC, Christian PJ, Marion SL, Hoyer PB. Effect of duration of dosing on onset of ovarian failure in a chemical-induced mouse model of perimenopause. Menopause 13: 482-488, 2006.
22. Maher JM, Cheng X, Tanaka Y, Scheffer GL, Klaassen CD. Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. Biochem Pharmacol 71: 1470-1478, 2006.
23. Mankhey RW, Bhatti F, Maric C. 17β-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 288: F399-F405, 2005.
24. Matthews KA, Santoro N, Lasley B, Chang Y, Crawford S, Pasternak RC, Sutton-Tyrrell K, Sowers M. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab 91: 1789-1795, 2006.
25. Mayer LP, Devine PJ, Dyer CA, Hoyer PB. The follicle-deplete mouse ovary produces androgen. Biol Reprod 71: 130-138, 2004.
26. McReynolds MR, Taylor-Garcia KM, Greer KA, Hoying JB, Brooks HL. Renal medullary gene expression in aquaporin-1 null mice. Am J Physiol Renal Physiol 288: F315-F321, 2005.
27. Middleton RJ, Bulfield G. Steroid regulation of kidney histidine decarboxylase and ornithine decarboxylase levels in mouse kidney: effects of the mutation testicular feminization, Tfm. Comp Biochem Physiol B 90: 221-225, 1988.
28. Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 159: 392-402, 1993.
29. Muramatsu T. The midkine family of growth/ differentiation factors. (midkine/pleiotrophin/retinoic acid/neurotrophic factors/embryonal carcinoma cells). Dev Growth Differ 36: 1-8, 1994.
30. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11: 319-329, 2000.
31. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39: 1116-1124, 1990. (Pubitemid 20263324)
32. Pines J. Cell cycle: reaching for a role for the Cks proteins. Curr Biol 6: 1399-1402, 1996.
33. Riazi S, Maric C, Ecelbarger CA. 17β-Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters. Kidney Int 69: 471-480, 2006.
34. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386, 2000.
35. Sato W, Yuzawa Y, Kadomatsu K, Tayasu T, Muramatsu H, Muramatsu T, Matsuo S. Midkine expression in the course of nephrogenesis and its role in ischaemic reperfusion injury. Nephrol Dial Transplant 17 Suppl 9: 52-54, 2002.
36. Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, Muramatsu T. Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167: 3463-3469, 2001.
37. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 25: 971-1010, 2004.
38. Seliger SL, Davis C, Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 10: 219-225, 2001.
39. Sowers MR, Wildman RP, Mancuso P, Eyvazzadeh AD, Karvonen-Gutierrez CA, Rillamas-Sun E, Jannausch ML. Change in adipocytokines and ghrelin with menopause. Maturitas 59: 149-157, 2008.
40. Tomomura M, Kadomatsu K, Matsubara S, Muramatsu T. A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem 265: 10765-10770, 1990. (Pubitemid 120001045)
41. Ushiroyama T, Sugimoto O. Endocrine function of the peri- and postmenopausal ovary. Horm Res 44: 64-68, 1995.
42. Wang S, Wu H, Liu Y, Sun J, Zhao Z, Chen Q, Guo M, Ma D, Zhang Z. Expression of USP2-69 in mesangial cells in vivo and in vitro. Pathol Int 60: 184-192, 2010.
43. Wu MX. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis 8: 11-18, 2003.
44. Zhang L, Rees MC, Bicknell R. The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci 108: 323-331, 1995.